CKD-333
/ Chong Kun Dang
- LARVOL DELTA
Home
Next
Prev
1 to 4
Of
4
Go to page
1
November 13, 2020
A Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics of CKD-333 or Co-administration of CKD-333 and D085 in Healthy Volunteers
(clinicaltrials.gov)
- P1; N=51; Not yet recruiting; Sponsor: Chong Kun Dang Pharmaceutical
Clinical • New P1 trial • Cardiovascular
November 02, 2020
Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-333 Low Dose in Healthy Volunteers
(clinicaltrials.gov)
- P1; N=51; Not yet recruiting; Sponsor: Chong Kun Dang Pharmaceutical
Clinical • New P1 trial • Cardiovascular
July 20, 2020
Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics in Healthy Volunteers
(clinicaltrials.gov)
- P1; N=51; Not yet recruiting; Sponsor: Chong Kun Dang Pharmaceutical
Clinical • New P1 trial • Cardiovascular
January 30, 2020
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of CKD-333 in Healthy Volunteers
(clinicaltrials.gov)
- P1; N=24; Completed; Sponsor: Chong Kun Dang Pharmaceutical; Not yet recruiting ➔ Completed
Trial completion
1 to 4
Of
4
Go to page
1